Shenmai Injection enhances short-term outcomes in ischemic stroke patients after thrombolysis via AMPKα1
SMI significantly improves short-term outcomes in IS patients treated with rt-PA thrombolysis. Its protective effects are likely mediated through the AMPKα1, highlighting its potential as an adjunctive therapy for IS.
Authors
- Le Wang (ORCID: https://orcid.org/0000-0001-6455-3235)
- Jinmin Liu (ORCID: https://orcid.org/0000-0003-2861-3514)
- Jing Wu (ORCID: https://orcid.org/0000-0001-7735-0349)
- Zhonghao Li (ORCID: https://orcid.org/0000-0001-8427-5818)
- Xiaoke Dong
Institutions
- Beijing University of Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
- Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3389/fphar.2025.1552493
- Citations
- 1
- Primary Topic
- Ginseng Biological Effects and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Fundamental Research Funds for the Central Universities